Study Summary
This trial is testing a botanical agent called Anti-tumor B to see if it can shrink tumors. The study is comparing it to a placebo (fake treatment) to see if it is effective.
- Squamous Cell Carcinoma of the Mouth
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: Baseline and following surgery (seven to 28 days after baseline)
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Anti-tumor B
1 of 2
Placebo
1 of 2
Active Control
Non-Treatment Group
28 Total Participants · 2 Treatment Groups
Primary Treatment: Anti-tumor B · Has Placebo Group · Phase < 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 11 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is this research endeavor actively enrolling participants?
"Affirmative. Clinicaltrials.gov has information that suggests this medical study is now recruiting people interested in participating. The trial was introduced on April 22nd 2022, and a recent update to the posting occurred on the same date. 28 participants need to be recruited from just one centre for the trial's completion." - Anonymous Online Contributor
How many participants are being investigated as part of this research endeavor?
"Affirmative. The information on clinicaltrials.gov attests that this scientific research project, initially posted April 22nd 2022 is presently recruiting patients. Twenty-eight participants are required across a single center." - Anonymous Online Contributor